Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary
- PMID: 29307368
- DOI: 10.1016/j.vaccine.2017.10.065
Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary
Abstract
Measles, a vaccine-preventable illness, is one of the most infectious diseases known to man. In 2015, an estimated 134,200 measles deaths occurred globally. Rubella, also vaccine-preventable, is a concern because infection during pregnancy can result in congenital defects in the baby. More than 100,000 babies with congenital rubella syndrome were estimated to have been born globally in 2010. Eradication of both measles and rubella is considered to be feasible, beneficial, and more cost-effective than high-level control. All six World Health Organization (WHO) regions have measles elimination goals by 2020 and two have rubella elimination goals by that year. However, the World Health Assembly has not endorsed a global eradication goal for either disease. In 2012, the Measles and Rubella Initiative published a Global Measles and Rubella Strategic Plan, 2012-2020, referred to hereafter as the Plan, which aimed to achieve measles and rubella elimination in at least five WHO regions by end-2020 through the implementation of five core strategies, with progress evaluated against 2015 milestones. When, by end-2015, none of these milestones had been met, WHO's Strategic Advisory Group of Experts on Immunization (SAGE) recommended a mid-term review of the Plan to evaluate progress toward goals, assess the quality of strategy implementation, and formulate lessons learned. A five-member team reviewed documents and conducted interviews with stakeholders as the basis for the review's conclusions and recommendations. This team concluded that, although significant progress in measles elimination had been made, progress had slowed. It recommended that countries continue to work toward elimination goals with a focus on strengthening ongoing immunization systems. In addition, it concluded that the strategies articulated in the Plan were sound, however full implementation had been impeded by inadequate country ownership and global political will, reflected in inadequate resources. Detailed recommendations for each of the Plan's five strategies as well as the areas of polio transition, governance and resource mobilization are outlined.
Keywords: Evaluation; Immunization; Measles; Recommendations; Rubella.
Copyright © 2017 World Health Organization. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Measles and Rubella Global Strategic Plan 2012-2020 midterm review.Vaccine. 2018 Jan 11;36 Suppl 1:A1-A34. doi: 10.1016/j.vaccine.2017.09.026. Vaccine. 2018. PMID: 29307367 Review.
-
Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.Vaccine. 2019 Sep 10;37(38):5745-5753. doi: 10.1016/j.vaccine.2019.02.058. Epub 2019 Mar 18. Vaccine. 2019. PMID: 30898393 Free PMC article.
-
Global Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - 2000-2014.MMWR Morb Mortal Wkly Rep. 2015 Sep 25;64(37):1052-5. doi: 10.15585/mmwr.mm6437a5. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26401958
-
Strengthening routine immunization through measles-rubella elimination.Vaccine. 2018 Sep 5;36(37):5645-5650. doi: 10.1016/j.vaccine.2018.07.029. Epub 2018 Jul 21. Vaccine. 2018. PMID: 30041881 Free PMC article.
-
The end of measles and congenital rubella: an achievable dream?Ann Ig. 2017 Jan-Feb;29(1):1-26. doi: 10.7416/ai.2017.2128. Ann Ig. 2017. PMID: 28067934
Cited by
-
Serosurveillance for Measles and Rubella.Vaccines (Basel). 2024 Jul 22;12(7):816. doi: 10.3390/vaccines12070816. Vaccines (Basel). 2024. PMID: 39066453 Free PMC article. Review.
-
Response to Measles, Mumps and Rubella (MMR) Vaccine in Transfusion-Dependent Patients.Vaccines (Basel). 2021 May 27;9(6):561. doi: 10.3390/vaccines9060561. Vaccines (Basel). 2021. PMID: 34072263 Free PMC article.
-
Assessment of knowledge and attitude among postnatal mothers towards childhood vaccination in Malaysia.Hum Vaccin Immunother. 2019;15(11):2544-2551. doi: 10.1080/21645515.2019.1612666. Epub 2019 Jun 20. Hum Vaccin Immunother. 2019. PMID: 31070987 Free PMC article.
-
Measles outbreak investigation in Berhet District, North Shewa, Ethiopia.Front Public Health. 2024 May 2;12:1330205. doi: 10.3389/fpubh.2024.1330205. eCollection 2024. Front Public Health. 2024. PMID: 38756880 Free PMC article.
-
Epidemiological characteristics of a protracted and widespread measles outbreak in the Democratic Republic of Congo, 2018 - 2020.Pan Afr Med J. 2022 Aug 15;42:282. doi: 10.11604/pamj.2022.42.282.34410. eCollection 2022. Pan Afr Med J. 2022. PMID: 36405650 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous